{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2021-N-0874\" and posted_year = 2023 sorted by posted_date descending", "rows": [["FDA-2021-N-0874-0085", "FDA", "FDA-2021-N-0874", "Letter from FDA CDER to OCS", "Other", "Letter(s)", "2023-12-20T05:00:00Z", 2023, 12, "2023-12-20T05:00:00Z", null, "2023-12-20T15:44:09Z", null, 0, 0, "090000648634b732"], ["FDA-2021-N-0874-0084", "FDA", "FDA-2021-N-0874", "Intarcia Appeal Exceptions Re ITCA 650 EMDAC Hearing - Material Issues Of Fact On Record Vs DDLO Assertions - Sub To Dr. Bumpus 10-10-23 FF_", "Other", "Presentation", "2023-11-13T05:00:00Z", 2023, 11, "2023-11-13T05:00:00Z", null, "2023-11-13T19:25:02Z", null, 0, 0, "09000064861e3c29"], ["FDA-2021-N-0874-0083", "FDA", "FDA-2021-N-0874", "Intarcia's Appeal of EMDAC Hearing Initial Decision - Exceptions Filed Material Issues of Fact For Dr. Bumpus @ FDA 10-10-23", "Other", "Decision", "2023-11-03T04:00:00Z", 2023, 11, "2023-11-03T04:00:00Z", null, "2023-11-03T18:01:50Z", null, 0, 0, "09000064861e2089"], ["FDA-2021-N-0874-0082", "FDA", "FDA-2021-N-0874", "ITCA 650, clarifying facts about CDERs erroneous statements about device performance", "Other", "Correspondence", "2023-10-24T04:00:00Z", 2023, 10, "2023-10-24T04:00:00Z", null, "2023-10-24T21:11:43Z", null, 0, 0, "09000064861294a1"], ["FDA-2021-N-0874-0080", "FDA", "FDA-2021-N-0874", "A Brief Summary of the Medici Technology & ITCA 650", "Other", "Summary (SUM)", "2023-10-23T04:00:00Z", 2023, 10, "2023-10-23T04:00:00Z", null, "2023-10-23T19:12:01Z", null, 0, 0, "0900006486124e1b"], ["FDA-2021-N-0874-0081", "FDA", "FDA-2021-N-0874", "Letter from Technical Operations, Intarcia to FDA OC", "Other", "Letter(s)", "2023-10-23T04:00:00Z", 2023, 10, "2023-10-23T04:00:00Z", null, "2023-10-23T19:20:10Z", null, 0, 0, "0900006486124e1d"], ["FDA-2021-N-0874-0079", "FDA", "FDA-2021-N-0874", "Letter from FDA OC to Hogan Lovells LLP RE Intarcia Therapeutics, Inc. Hearing Request for NDA 209053", "Other", "Letter(s)", "2023-06-05T04:00:00Z", 2023, 6, "2023-06-05T04:00:00Z", null, "2023-06-05T14:13:04Z", null, 0, 0, "0900006485ab986e"], ["FDA-2021-N-0874-0078", "FDA", "FDA-2021-N-0874", "Comment from Hogan Lovells US LLP", "Supporting & Related Material", "Background Material", "2023-05-30T04:00:00Z", 2023, 5, null, null, "2023-05-30T12:43:39Z", null, 0, 0, "0900006485a4835c"], ["FDA-2021-N-0874-0077", "FDA", "FDA-2021-N-0874", "Letter from FDA OC Re Intarcia Therapeutics, Inc. Hearing Request for NDA 209053 ITCA 650 (exenatide in DUROS device)", "Other", "Letter(s)", "2023-04-28T04:00:00Z", 2023, 4, "2023-04-28T04:00:00Z", null, "2023-04-28T12:29:34Z", null, 0, 0, "090000648599a397"], ["FDA-2021-N-0874-0071", "FDA", "FDA-2021-N-0874", "Citizen Petition from Hogan Lovells US LLP on behalf of Intarcia Therapeutics Inc", "Other", "Citizen Petition", "2023-04-14T04:00:00Z", 2023, 4, "2023-04-14T04:00:00Z", null, "2024-11-07T00:49:31Z", null, 1, 0, "0900006485942f3f"], ["FDA-2021-N-0874-0075", "FDA", "FDA-2021-N-0874", "April 3 2023 Meeting Minutes re ITCA 650", "Other", "Minutes", "2023-04-14T04:00:00Z", 2023, 4, "2023-04-14T04:00:00Z", null, "2023-04-14T16:17:20Z", null, 0, 0, "090000648594a13c"], ["FDA-2021-N-0874-0074", "FDA", "FDA-2021-N-0874", "Attachment 1 RE: Citizen Petition from Hogan Lovells US LLP on behalf of Intarcia Therapeutics Inc", "Supporting & Related Material", "Background Material", "2023-04-14T04:00:00Z", 2023, 4, null, null, "2023-04-14T13:49:43Z", null, 0, 0, "0900006485949310"], ["FDA-2021-N-0874-0072", "FDA", "FDA-2021-N-0874", "Acknowledgment Letter from FDA DMS to Hogan Lovells US LLP on behalf of Intarcia", "Other", "Acknowledgement Letter/Receipt", "2023-04-14T04:00:00Z", 2023, 4, "2023-04-14T04:00:00Z", null, "2023-04-14T13:42:16Z", null, 0, 0, "090000648594930c"], ["FDA-2021-N-0874-0073", "FDA", "FDA-2021-N-0874", "Comment on Citizen Petition: Intarcia Therapeutics, Inc.\u2019s Request for a Part 14 Hearing on ITCA 650 RE Citizen Petition from Hogan Lovells US LLP on behalf of Intarcia Therapeutics Inc", "Other", "Response(s)", "2023-04-14T04:00:00Z", 2023, 4, "2023-04-14T04:00:00Z", null, "2023-04-14T13:42:42Z", null, 0, 0, "090000648594930e"], ["FDA-2021-N-0874-0076", "FDA", "FDA-2021-N-0874", "Letter to Intarcia and CDER re ITCA 650 April 14 2023 final", "Other", "Letter(s)", "2023-04-14T04:00:00Z", 2023, 4, "2023-04-14T04:00:00Z", null, "2023-04-14T16:17:25Z", null, 0, 0, "090000648594a13e"], ["FDA-2021-N-0874-0070", "FDA", "FDA-2021-N-0874", "Letter from FDA CDER to Hogan Lovells LLP and FDA OC", "Other", "Letter(s)", "2023-03-27T04:00:00Z", 2023, 3, "2023-03-27T04:00:00Z", null, "2023-03-27T12:57:18Z", null, 0, 0, "09000064858473d9"], ["FDA-2021-N-0874-0069", "FDA", "FDA-2021-N-0874", "Memorandum - Separation of Functions; Proposal To Refuse To Approve a New Drug Application for ITCA 650 (Exenatide in DUROS Device); Opportunity for a Hearing", "Other", "Memorandum", "2023-03-22T04:00:00Z", 2023, 3, "2023-03-22T04:00:00Z", null, "2023-03-22T18:35:04Z", null, 0, 0, "0900006485824496"], ["FDA-2021-N-0874-0068", "FDA", "FDA-2021-N-0874", "Letter from Hogan Lovells US LLP", "Other", "Letter(s)", "2023-02-27T05:00:00Z", 2023, 2, "2023-02-27T05:00:00Z", null, "2023-02-27T19:14:12Z", null, 0, 0, "09000064856d5437"], ["FDA-2021-N-0874-0067", "FDA", "FDA-2021-N-0874", "CDER Memo Re Intarcia Part 14 FINAL", "Other", "Memorandum", "2023-02-15T05:00:00Z", 2023, 2, "2023-02-15T05:00:00Z", null, "2023-02-15T21:13:51Z", null, 0, 0, "09000064856a3c6c"], ["FDA-2021-N-0874-0066", "FDA", "FDA-2021-N-0874", "Letter from FDA OC to Hogan Lovells LLP and FDA CDER", "Other", "Letter(s)", "2023-02-07T05:00:00Z", 2023, 2, "2023-02-07T05:00:00Z", null, "2023-02-07T20:26:45Z", null, 0, 0, "090000648563c2dc"]], "truncated": false, "filtered_table_rows_count": 20, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 and \"posted_year\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA-2021-N-0874", "p1": "2023"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2021-N-0874&posted_year=2023", "results": [{"value": "FDA", "label": "FDA", "count": 20, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-0874&posted_year=2023&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2021-N-0874&posted_year=2023", "results": [{"value": "Other", "label": "Other", "count": 18, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-0874&posted_year=2023&document_type=Other", "selected": false}, {"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-0874&posted_year=2023&document_type=Supporting+%26+Related+Material", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2021-N-0874&posted_year=2023", "results": [{"value": 2023, "label": 2023, "count": 20, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-0874", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-0874&posted_year=2023&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-0874&posted_year=2023&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-0874&posted_year=2023&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-0874&posted_year=2023&_facet=comment_start_date"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-0874&posted_year=2023&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-0874&posted_year=2023&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-0874&posted_year=2023&_facet_date=comment_start_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-0874&posted_year=2023&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 1086.2258049892262, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}